Table 1.
Diabetic medications taken during the study. DFU study subjects listed by number with their prestudy medications for glycemic control. Healed indicates subjects with healed study DFU wounds at the completion of the twelve-week observation period. TIDM indicates study subject with type I DM; all other subjects are with type II DM.
| Patient number | Prior therapy | DFU status |
|---|---|---|
| 1 | Tradjenta (linagliptin) | Nonhealing |
| 2 | Lantus/Humalog Insulin | Nonhealing |
| 3 | Glimepiride | Nonhealing |
| 4 | Glipizide; Metformin | Healed |
| 5 | Lantus/Humalog Insulin | Nonhealing |
| 6 | Humalog/Humulin N Insulin | Nonhealing |
| 7 | Humalog/Humulin N Insulin (TIDM) | Nonhealing |
| 8 | Humulin 70/30 Insulin | Nonhealing |
| 9 | Glipizide/Novolog and Lantus Insulin | Healed |
| 10 | Glimepiride/Victoza and Invokana Insulin | Nonhealing |
| 11 | Glyburide/Lantus and Humalog Insulin; Metformin | Healed |
| 12 | Glimepiride; Metformin | Nonhealing |
| 13 | Humulin 70/30 Insulin | Nonhealing |
| 14 | Lantus Insulin | Nonhealing |
| 15 | Novolog and Lantus Insulin | Nonhealing |
| 16 | Lantus and Novolog Insulin, Metformin | Nonhealing |
| 17 | Novolin N and Novolin R Insulin; Actos | Nonhealing |
| 18 | Glipizide, Metformin, Januvia | Nonhealing |